Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,326 | 3 | 84.1% |
| Food and Beverage | $249.81 | 3 | 15.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $1,326 | 3 | $0 (2018) |
| Biogen, Inc. | $235.55 | 2 | $0 (2017) |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | $14.26 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $14.26 | 1 | BIODELIVERY SCIENCES INTERNATIONAL, INC. ($14.26) |
| 2018 | $1,326 | 3 | Celgene Corporation ($1,326) |
| 2017 | $235.55 | 2 | Biogen, Inc. ($235.55) |
All Payment Transactions
6 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/15/2020 | BIODELIVERY SCIENCES INTERNATIONAL, INC. | — | Food and Beverage | In-kind items and services | $14.26 | General |
| 10/22/2018 | Celgene Corporation | Ozanimod (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $442.00 | General |
| 10/22/2018 | Celgene Corporation | Ozanimod (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $442.00 | General |
| 10/22/2018 | Celgene Corporation | Ozanimod (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $442.00 | General |
| 10/17/2017 | Biogen, Inc. | — | Food and Beverage | Cash or cash equivalent | $121.97 | General |
| 03/28/2017 | Biogen, Inc. | TECFIDERA (Drug) | Food and Beverage | Cash or cash equivalent | $113.58 | General |
| Category: NEUROLOGY | ||||||
About Dr. Michael Wagner, MD
Dr. Michael Wagner, MD is a Neurology healthcare provider based in Portsmouth, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558324962.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Wagner, MD has received a total of $1,576 in payments from pharmaceutical and medical device companies, with $14.26 received in 2020. These payments were reported across 6 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1,326).
Practice Information
- Specialty Neurology
- Location Portsmouth, VA
- Active Since 04/07/2006
- Last Updated 07/08/2007
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1558324962
Products in Payments
- Ozanimod (Drug) $1,326
- TECFIDERA (Drug) $113.58
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Portsmouth
Augusto Juguilon, M.d, M.D
Neurology — Payments: $4,380
Joshua Gear, M.d, M.D
Neurology — Payments: $3,781
Leon Rosenberg, Md, MD
Neurology — Payments: $1,412
Susanne Patrick-Mackinnon, Md, MD
Neurology — Payments: $597.23
Dr. Patricia Locuratolo, Md, MD
Neurology — Payments: $226.86
Angela Rackley, Md, MD
Neurology — Payments: $203.53